Lay Summary
Bile Acid Pathways in PSC-IBD
Are the mechanisms that drive inflammation in the bowel in people with PSC different to that seen in people with UC alone? Dr Nabil Quraishi
Read MoreEffects of PSC on Risks of Cancer in People with IBD
A new study has looked at the health records of people with IBD to understand what happens to them if they develop PSC.
Read MoreALP and the ELF Score in Clinical Trials
On 21 July, research about alkaline phosphatase (ALP) and the enhanced liver fibrosis (ELF) score and PSC was published.
Read MorePSC Patient Insights Survey Part 2
Patient Insights Report – PSC Clinical Trials reports on attitudes to PSC research and study design and makes recommendations to improve recruitment.
Read MoreVITTAL Study Summary
The VITTAL Study investigated the use of a new technology called NMP to see if it allowed more transplants to safely take place.
Read MoreThe 6 Cs of Primary Sclerosing Cholangitis
The 6Cs that all PSC doctors should be thinking about:
Covert, Cholangitis, Cirrhosis, Colitis, Cancer, CURE
Care of Patients with Liver Disease during the COVID-19 Pandemic
Care of liver disease patients during COVID-19 – summary of guidance for healthcare professionals (written by PSC Support and EASL).
Read MoreThe PSC Wellbeing Study Update
Researchers have today published an article based on learning from research funded by PSC Support called the PSC Wellbeing Project.
Read MoreLiver Perfusion Could Save 7 in 10 Rejected Donor Livers
New research from the University of Birmingham reveals results of clinical trial about machine perfusion technology.
Read MorePSC Survey Insights Part 1
We are delighted to share our first insights following the PSC Support survey we launched last year to help shape PSC research design.
Read More